Home
Alnylam Pharmaceuticals ALNY spent $450K on lobbying in Q2 2026 · Pharmacy, Medicare and 1 more issue
Trade details
- Type
- Lobbying report
- Amount
- $450,000
- Quarter
- Q2 2026
- Client
- Alnylam Pharmaceuticals
- Reported
- 26/07/20
Up 4.7% from last quarter
What else happened in Alnylam Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 05/31~07/30Alnylam Pharmaceuticals's other lobbying reports
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$60K
$60K
Reported 07/20
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$60K
$60K
Reported 07/20
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$60K
$60K
Reported 07/19
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$30K
$30K
Reported 07/16
for Q2
- Alnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
LobbyingAlnylam Pharmaceuticals
ALNY
$50K
$50K
Reported 07/05
for Q2